Proteomics International Laboratories Ltd (ASX:PIQ)
Australia · Delayed Price · Currency is AUD 0.3150
-0.0050 (-1.56%)
Aug 29, 2025, 4:10 PM AEST
ASX:PIQ Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Operating Revenue | 0.96 | 0.89 | 0.73 | 1.49 | 1.31 | Upgrade |
Other Revenue | 2.4 | 2.38 | 2.45 | 1.94 | 1.42 | Upgrade |
| 3.36 | 3.28 | 3.18 | 3.43 | 2.74 | Upgrade | |
Revenue Growth (YoY) | 2.42% | 3.00% | -7.26% | 25.39% | 0.25% | Upgrade |
Cost of Revenue | 2.22 | 2.02 | 2.35 | 2.06 | 0.81 | Upgrade |
Gross Profit | 1.13 | 1.26 | 0.84 | 1.37 | 1.92 | Upgrade |
Selling, General & Admin | 6.94 | 5.88 | 5.82 | 4.91 | 3.77 | Upgrade |
Other Operating Expenses | 1.02 | 0.61 | 0.53 | 0.51 | 0.71 | Upgrade |
Operating Expenses | 9.36 | 8 | 7.2 | 6.35 | 5 | Upgrade |
Operating Income | -8.22 | -6.74 | -6.37 | -4.98 | -3.08 | Upgrade |
Interest Expense | -0.04 | -0.02 | - | -0 | -0.01 | Upgrade |
Interest & Investment Income | 0.2 | 0.28 | 0.14 | 0.01 | 0.01 | Upgrade |
Currency Exchange Gain (Loss) | -0.09 | -0.02 | -0.02 | 0 | -0.02 | Upgrade |
EBT Excluding Unusual Items | -8.15 | -6.5 | -6.25 | -4.97 | -3.1 | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.02 | 0.01 | - | 0.01 | Upgrade |
Other Unusual Items | - | - | - | - | 0.23 | Upgrade |
Pretax Income | -8.15 | -6.48 | -6.23 | -4.97 | -2.86 | Upgrade |
Earnings From Continuing Operations | -8.15 | -6.48 | -6.23 | -4.97 | -2.86 | Upgrade |
Minority Interest in Earnings | 0.04 | 0.11 | 0.06 | - | - | Upgrade |
Net Income | -8.11 | -6.38 | -6.18 | -4.97 | -2.86 | Upgrade |
Net Income to Common | -8.11 | -6.38 | -6.18 | -4.97 | -2.86 | Upgrade |
Shares Outstanding (Basic) | 134 | 126 | 116 | 106 | 102 | Upgrade |
Shares Outstanding (Diluted) | 134 | 126 | 116 | 106 | 102 | Upgrade |
Shares Change (YoY) | 6.69% | 8.07% | 10.35% | 3.76% | 16.34% | Upgrade |
EPS (Basic) | -0.06 | -0.05 | -0.05 | -0.05 | -0.03 | Upgrade |
EPS (Diluted) | -0.06 | -0.05 | -0.05 | -0.05 | -0.03 | Upgrade |
Free Cash Flow | -6.63 | -6 | -6.91 | -3.67 | -2.41 | Upgrade |
Free Cash Flow Per Share | -0.05 | -0.05 | -0.06 | -0.04 | -0.02 | Upgrade |
Gross Margin | 33.81% | 38.49% | 26.27% | 40.01% | 70.25% | Upgrade |
Operating Margin | -245.09% | -205.74% | -200.11% | -145.10% | -112.68% | Upgrade |
Profit Margin | -241.84% | -194.62% | -194.17% | -144.98% | -104.53% | Upgrade |
Free Cash Flow Margin | -197.71% | -183.02% | -217.25% | -106.97% | -88.25% | Upgrade |
EBITDA | -7.75 | -6.11 | -5.84 | -4.56 | -2.77 | Upgrade |
EBITDA Margin | -230.90% | -186.60% | -183.46% | -132.95% | -101.40% | Upgrade |
D&A For EBITDA | 0.48 | 0.63 | 0.53 | 0.42 | 0.31 | Upgrade |
EBIT | -8.22 | -6.74 | -6.37 | -4.98 | -3.08 | Upgrade |
EBIT Margin | -245.09% | -205.74% | -200.11% | -145.10% | -112.68% | Upgrade |
Revenue as Reported | 3.51 | 3.57 | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.